Emerging Healthcare Solutions, Inc. Forms Joint Venture to Develop Stem-Cell Treatment for Liver Disease

HOUSTON--(BUSINESS WIRE)--Emerging Healthcare Solutions, Inc. (PinkSheets: EHSI) announced today that it has entered into a joint venture agreement with its wholly owned subsidiary, Celulas Genetica, in order to pursue testing of the revolutionary Rutherford Procedure using a NASA bioreactor.

MORE ON THIS TOPIC